Cell and gene therapies (CGTs) are the fastest growing area of therapeutics, with many preclinical and clinical programmes currently underway.

While cancer is key target for CGTs, these advanced therapies are also under investigation to treat conditions as varied as asthma, multiple sclerosis, ophthalmological conditions like age-related macular degeneration, osteoarthritis, and heart failure.

With so many CGTs under investigation, the pipeline seems robust, however, as with any new technology, these therapies come at a very high cost and it may take time for current health systems to adjust to a different type of medicine. New approaches to how advanced therapies are regulated and funded may be necessary for these treatments to reach the patients that need them.

This eBook, sponsored by PHCbi, explores the current challenges and opportunities in the CGT space, and the factors likely to influence this area of therapeutics in the future.

Download this exclusive eBook to learn more about:

  • How innovative approaches are taking CGTs from bench to bedside
  • The importance of the right preclinical model to advance AAV-based gene therapies
  • The possibilities of using natural killer cell therapy to treat Alzheimer’s
  • Why vertical AI is set to reshape the cell and gene therapy sector

Download now.